Home

STEPHEN A HILL

CIK 1237404 · President, CEO · last filed 2020-12-17

STEPHEN A HILL is a President, CEO who has filed 38 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for LPCN, was dated Dec 17, 2020. Across all open-market trades the lifetime net is +$82.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.9K

Companies

5

Total Filings

38

Lifetime Open-Market Net

$82.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LPCN Director 750 $2.14 $1.6K $15.5K 9 2020-12-17
Cellectar Biosciences, Inc. (CLRBZ) Delisted Director 18,000 $0.12 $2.1K $17.2K 6 2020-06-25
CBIO Director 79 $16.44 $1.3K $10.1K 9 2018-09-06
Cellectar Biosciences, Inc. (CLRB.W) Delisted Director 5,300 — — $19.9K 4 2016-07-06
Cellectar Biosciences, Inc. (CLRB.Z) Delisted Director 9,920 — — $19.9K 1 2016-04-21

Recent Filings

38 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-12-17 LPCN Exer (M) +7,500 $0 EDGAR
2020-06-25 Cellectar Biosciences, Inc. (CLRBZ) Delisted Grant (A) — $0 EDGAR
2020-06-10 LPCN Grant (A) — $0 EDGAR
2020-06-08 Cellectar Biosciences, Inc. (CLRBZ) Delisted Buy (P) +18,000 $19.4K EDGAR
2019-06-14 Cellectar Biosciences, Inc. (CLRBZ) Delisted Grant (A) — $0 EDGAR
2019-06-14 LPCN Grant (A) — $0 EDGAR
2018-11-30 Cellectar Biosciences, Inc. (CLRBZ) Delisted Sell (S) −992 -$2.2K EDGAR
2018-10-15 Cellectar Biosciences, Inc. (CLRBZ) Delisted Grant (A) — $0 EDGAR
2018-09-06 CBIO Disp (D) −190 -$1.9K EDGAR
2018-06-28 LPCN Grant (A) — $0 EDGAR
Showing 1–10 of 38
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.